• Category: Medical Devices
  • Investment Status: Incubator
  • Medical Field: Neurology
  • Development Status: R&D

InVatin Technologies Ltd. is developing the SYNAXIS-XT: The ultimate solution for stroke prevention in high risk patients.

Our solution is an aortic arch, uni-axial, diverter designed to deliver embolic protection to all three arteries ascending from the aortic arch, minimizing the risk for cerebral ischemic stroke. The device contains a unique mechanical barrier which redirects emboli away from the brain while preserving blood flow patterns and maintaining uncompromised stent patency. This novel technology marks a paradigm shift in stroke prevention for high risk patients; A paradigm in which patients can be protected from stroke regardless of the origin of the embolic substance, or underlying condition.